Here are my recommended weekly reads for The Niche readership for early February 2021 including COVID-19 and stem cell lawsuit updates, papers, and more. How many papers do you end up reading each week or month these days? More or less than before the pandemic? COVID-19 updates New diabetes cases linked to covid-19, WaPo ICYMI …
The Niche reads: COVID, new INDs, clinic suits, papers Read More »
A grand jury indicted Missouri state representative and assistant physician Patricia Derges for allegedly selling and injecting patients with fake stem cells. The injection was reportedly just of amniotic fluid, but Derges allegedly claimed it was a stem cell treatment. NBC News was one of several media outlets that broke the story here after the …
Lawmaker indicted for selling fake stem cells for COVID & more Read More »
Sometimes it seems like a theme spontaneously emerges in pubs that I want to read for a given week like the set of single-cell analysis papers but there are diverse, other items including a striking day-night brain stem cell cycle paper and an interesting piece on identical twins who got COVID. What are you reading …
Recommended reads: Single-cell work, COVID twin study, more Read More »
A new paper today in Stem Cells Translational Medicine on a small COVID-19 Phase 1/2a trial using an umbilical cord stem cell product reports a surprising degree of possible efficacy. What’s the scoop here and could there be some hype in the media about this new study such as one of the authors describing the …
Small umbilical cord stem cell COVID-19 trial: sign of efficacy? Read More »
I’ve been closely following the arena of stem cells for COVID-19 since the pandemic broke including the efforts of Mesoblast. Mesoblast unlikely to meet primary endpoints in Phase III COVID trial Now, the firm got bad news as its DSMB reported that they are unlikely to meet the primary endpoint for their Phase III trial …
Mesoblast stock hit on gloomy data on stem cells for COVID-19 Read More »
This week we have some interesting new reading including both on the stem cell basic and translational fronts as well as on COVID-19 vaccines. COVID-19 vaccine considerations From Derek Lowe at In The Pipeline on COVID-19 vaccine expectations at Science Translational Medicine, Get Ready for False Side Effects. You can read my views on possible …
Recommended stem cell reads: retractions, aging, COVID, CRISPR soldiers Read More »
The COVID-19 pandemic is tearing through the country right as we are starting into the holiday season, but the wheels of science including cell biology keep going and we keep reading all the great work. What news or papers caught your eye? Here are some of the things I have on my list of reading. …
Weekend cell biology reads: Mesoblast COVID-19 deal, pubs Read More »
I’m not a virologist, but I’m still getting asked these days about what the risks might be from the new generation of RNA vaccines for COVID-19. Approaching this question instead as a biologist and genetics/genomics researcher, I can see a handful of at least hypothetical risks. Below I discuss these possible risks and why I’m …
Why I’m planning to get a COVID-19 RNA vaccine: low, mostly theoretical risks Read More »
There have been many other interesting scientific and specifically regenerative medicine developments and papers this past week including with CIRM and exciting CIRM funding to UC Davis so read on, but first a somewhat random question: are you more of a cat person or dog person? I’d say I’m both. But our big dog is …
Weekly reads: cats, COVID, Muse cells, cancer stem cells, MS Read More »
As a researcher, is there ever enough time to get to everything that you want to read especially in newer areas like stem cells, organoids, and CRISPR, without even including non-scientific reads like Shakespeare or a new novel or something like that? Hopefully, putting together lists of recommended reads like today’s post is helpful. I …
Weekly reads on organoids, COVID, CRISPR, cold chromatin, more Read More »